BRCA1 and BRCA2: different roles in a common pathway of genome protection
R Roy, J Chun, SN Powell - Nature Reviews Cancer, 2012 - nature.com
The proteins encoded by the two major breast cancer susceptibility genes, BRCA1 and
BRCA2, work in a common pathway of genome protection. However, the two proteins work …
BRCA2, work in a common pathway of genome protection. However, the two proteins work …
Hallmarks of'BRCAness' in sporadic cancers
N Turner, A Tutt, A Ashworth - Nature reviews cancer, 2004 - nature.com
Germline mutations in the BRCA1, BRCA2 and Fanconi anaemia genes confer cancer
susceptibility, and the proteins encoded by these genes have distinct functions in related …
susceptibility, and the proteins encoded by these genes have distinct functions in related …
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
ContextGene expression analysis has identified several breast cancer subtypes, including
basal-like, human epidermal growth factor receptor-2 positive/estrogen receptor negative …
basal-like, human epidermal growth factor receptor-2 positive/estrogen receptor negative …
World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs
TY Chan - Urology, 2005 - goldjournal.net
This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
[HTML][HTML] Triple-negative breast cancer—current status and future directions
Triple-negative breast cancer (TNBC) is defined by a lack of expression of both estrogen
and progesterone receptor as well as human epidermal growth factor receptor 2. It is …
and progesterone receptor as well as human epidermal growth factor receptor 2. It is …
[HTML][HTML] Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Background Although numerous mouse models of breast carcinomas have been developed,
we do not know the extent to which any faithfully represent clinically significant human …
we do not know the extent to which any faithfully represent clinically significant human …
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller, JM Silva, G Dominguez… - JNCI: Journal of the …, 2000 - academic.oup.com
Background: Inherited mutations in the BRCA1 gene may be responsible for almost half of
inherited breast carcinomas. However, somatic (acquired) mutations in BRCA1 have not …
inherited breast carcinomas. However, somatic (acquired) mutations in BRCA1 have not …
Triple-negative breast cancer: therapeutic options
S Cleator, W Heller, RC Coombes - The lancet oncology, 2007 - thelancet.com
Triple-negative breast cancers are defined by a lack of expression of oestrogen,
progesterone, and ERBB2 receptors. This subgroup accounts for 15% of all types of breast …
progesterone, and ERBB2 receptors. This subgroup accounts for 15% of all types of breast …
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers, R Meuwissen, H van der Gulden… - Nature …, 2001 - nature.com
Inheritance of one defective BRCA2 allele predisposes humans to breast cancer. To
establish a mouse model for BRCA2-associated breast cancer, we generated mouse …
establish a mouse model for BRCA2-associated breast cancer, we generated mouse …
Cancer suppression by the chromosome custodians, BRCA1 and BRCA2
AR Venkitaraman - Science, 2014 - science.org
Germline mutations in BRCA1 and BRCA2 predispose to common human malignancies,
most notably tumors of the breast and ovaries. The proteins encoded by these genes have …
most notably tumors of the breast and ovaries. The proteins encoded by these genes have …